Literature DB >> 19003349

Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage.

A Preininger1, U Schlokat, G Mohr, M Himmelspach, V Stichler, A Kyd-Rebenburg, B Plaimauer, P L Turecek, H P Schwarz, W Wernhart, B E Fischer, F Dorner.   

Abstract

Coagulation factors, amongst many other proteins, often require posttranslational endoproteolytic processing for maturation. Upon high yield expression of recombinant forms of these proteins, processing frequently becomes severely limiting, resulting in a hampered function of the protein. In this report, the human endoprotease Furin was used to achieve complete propeptide removal from recombinant von Willebrand Factor (rvWF) precursors in CHO cells. At expression beyond 200 ng rvWF/106 cells x day, processing became insufficient. Stable co- and overexpression of full length Furin resulted in complete precursor cleavage in cell clones expressing 2 mug rvWF/106 cells x day. Rather than occuring intracellularly, processing was found to be mediated by a naturally secreted form of rFurin, present in 100 fold higher concentrations than endogenous Furin and accumulating in the cell culture supernatant. Attempts to increase rFurin yield by amplification, in order to ensure complete rvWF precursor processing at expression rates beyond 2 mug rvWF/106 cells x day, failed. Truncation of the trans-membrane domain resulted in immediate secretion of rFurin and approximately 10 fold higher concentrations in the conditioned medium. In cases where these high rFurin concentrations are not sufficient to ensure complete processing, an in vitro downstream processing procedure has to be established. Secreted affinity epitope-tagged rFurin derivatives were constructed, the fate of which, at expression, was dependent on the size of the C-terminal truncation and the type of the heterologous epitope added. A suitable candidate was purified by a one step affinity procedure, and successfully used for in vitro processing. This allows complete proteolytic processing of large amounts of precursor molecules by comparably small quantities of rFurin. Complete precursor cleavage of a target protein at expression rates of up to approximately 200 ng, 2 mug, and 20 mug, as well as beyond 20 mug/106 cells x day can thus be anticipated to be accomplished by endogenous Furin, additional expression of full length rFurin, co-expression of truncated and hence secreted rFurin, and a protein-chemical in vitro procedure, respectively.

Entities:  

Year:  1999        PMID: 19003349      PMCID: PMC3449942          DOI: 10.1023/A:1008030407679

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  43 in total

1.  In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease.

Authors:  P L Turecek; H Gritsch; L Pichler; W Auer; B Fischer; A Mitterer; W Mundt; U Schlokat; F Dorner; H J Brinkman; J A van Mourik; H P Schwarz
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

2.  Purification and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells.

Authors:  K Hatsuzawa; M Nagahama; S Takahashi; K Takada; K Murakami; K Nakayama
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

3.  Development and characterization of a panel of monoclonal antibodies against the novel subtilisin-like proprotein processing enzyme furin.

Authors:  H L van Duijnhoven; J W Creemers; M G Kranenborg; E D Timmer; A Groeneveld; A M van den Ouweland; A J Roebroek; W J van de Ven
Journal:  Hybridoma       Date:  1992-02

4.  Construction of plasmids that express E. coli beta-galactosidase in mammalian cells.

Authors:  G R MacGregor; C T Caskey
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

5.  PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway.

Authors:  L C Wasley; A Rehemtulla; J A Bristol; R J Kaufman
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

6.  Triplet structure of human von Willebrand factor.

Authors:  B E Fischer; K B Thomas; U Schlokat; F Dorner
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

7.  High mutation frequency in DNA transfected into mammalian cells.

Authors:  M P Calos; J S Lebkowski; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Structural analysis of recombinant von Willebrand factor: identification of hetero- and homo-dimers.

Authors:  B Fischer; A Mitterer; U Schlokat; R DenBouwmeester; F Dorner
Journal:  FEBS Lett       Date:  1994-09-12       Impact factor: 4.124

Review 9.  The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions.

Authors:  N G Seidah; M Chrétien; R Day
Journal:  Biochimie       Date:  1994       Impact factor: 4.079

10.  Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin.

Authors:  B E Fischer; U Schlokat; A Mitterer; M Reiter; W Mundt; P L Turecek; H P Schwarz; F Dorner
Journal:  FEBS Lett       Date:  1995-11-20       Impact factor: 4.124

View more
  5 in total

1.  'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus.

Authors:  B Plaimauer; G Mohr; W Wernhart; M Himmelspach; F Dorner; U Schlokat
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  Introduction to animal cell culture technology-past, present and future.

Authors:  O-W Merten
Journal:  Cytotechnology       Date:  2006-08-03       Impact factor: 2.058

3.  Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system.

Authors:  D G Ilyushin; O M Haertley; T V Bobik; O G Shamborant; E A Surina; V D Knorre; P Masson; I V Smirnov; A G Gabibov; N A Ponomarenko
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

4.  Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells.

Authors:  Saeedeh Ebadat; Samira Ahmadi; Maryam Ahmadi; Fatemeh Nematpour; Farzaneh Barkhordari; Reza Mahdian; Fatemeh Davami; Fereidoun Mahboudi
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

Review 5.  The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.

Authors:  Yvonne Adu-Agyeiwaah; Maria B Grant; Alexander G Obukhov
Journal:  Cells       Date:  2020-11-23       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.